0
Articles |

Respiratory Nitric Oxide Levels in Experimental Human Influenza

Andrew W. Murphy; Thomas A.E. Platts-Mills; Monica Lobo; Frederick Hayden
Author and Funding Information

Affiliations: From the Asthma and Allergic Diseases Center; and the Department of Medicine, University of Virginia School of Medicine, Charlottesville,  From the Department of Student Health, University of Virginia School of Medicine, Charlottesville,  From the Division of Epidemiology and Virology; and the Departments of Medicine and Pathology, University of Virginia School of Medicine, Charlottesville

Affiliations: From the Asthma and Allergic Diseases Center; and the Department of Medicine, University of Virginia School of Medicine, Charlottesville,  From the Department of Student Health, University of Virginia School of Medicine, Charlottesville,  From the Division of Epidemiology and Virology; and the Departments of Medicine and Pathology, University of Virginia School of Medicine, Charlottesville

Affiliations: From the Asthma and Allergic Diseases Center; and the Department of Medicine, University of Virginia School of Medicine, Charlottesville,  From the Department of Student Health, University of Virginia School of Medicine, Charlottesville,  From the Division of Epidemiology and Virology; and the Departments of Medicine and Pathology, University of Virginia School of Medicine, Charlottesville


1998 by the American College of Chest Physicians


Chest. 1998;114(2):452-456. doi:10.1378/chest.114.2.452
Text Size: A A A
Published online

Abstract

Background: Exhaled oral nitric oxide (NO), a reported marker of inflammation in the respiratory tract, can be elevated by "upper respiratory tract infections." However, the responsible viruses and the time course of this rise in NO are not clear.

Objective: To determine the expired nasal and oral NO levels during experimentally induced influenza A infection in 14 healthy volunteers without a history of asthma, rhinitis, or sinusitis.

Methods: After being housed in individual rooms, susceptible volunteers were inoculated with 106 50% tissue culture infective dose of influenza A/Texas/36/91/(H1N1) virus on a single occasion by intranasal drops. Volunteers remained in the isolation unit for 8 days and returned for follow-up 21 days after inoculation. Symptom scores and nasal washing for viral culture were obtained daily. NO samples from the mouth and nose were obtained on days 0 through 4, 8, and 21 by having the patient perform a slow vital capacity maneuver through a plastic tube into a Mylar balloon.

Results: All patients had influenza virus cultured from nasal washings (12 of 14 on day 1, 14 of 14 by day 5). Patient symptom scores peaked on day 3 (mean±SE; 15.4±3.2) and returned to baseline by day 8. Preinfection exhaled nasal NO (right, 28.4±3.7 parts per billion [ppb]; left, 27.7±4.6 ppb) was significantly higher than oral NO (5.8 ppb; p<0.001). Exhaled oral NO was significantly elevated on day 8 postinoculation (12.9±0.8 ppb; p<0.01 Bonferroni) and returned to baseline at follow-up. Nasal NO levels showed a slight decrease on days 2 to 4 but returned to baseline by day 8.

Conclusion: Experimental influenza virus infection can increase oral but not nasal exhaled NO levels. The timing of exhaled NO changes suggests that NO does not contribute to illness manifestations directly.


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543